loading
前日終値:
$11.00
開ける:
$11.11
24時間の取引高:
37,117
Relative Volume:
0.45
時価総額:
$163.35M
収益:
$166.88M
当期純損益:
$-74.18M
株価収益率:
-2.2419
EPS:
-5.07
ネットキャッシュフロー:
$1.14M
1週間 パフォーマンス:
+1.88%
1か月 パフォーマンス:
+4.40%
6か月 パフォーマンス:
-30.36%
1年 パフォーマンス:
-59.33%
1日の値動き範囲:
Value
$11.01
$11.53
1週間の範囲:
Value
$10.49
$11.56
52週間の値動き範囲:
Value
$10.47
$28.60

Anika Therapeutics Inc Stock (ANIK) Company Profile

Name
名前
Anika Therapeutics Inc
Name
セクター
Healthcare (1167)
Name
電話
(781) 457-9000
Name
住所
32 WIGGINS AVENUE, BEDFORD, MA
Name
職員
288
Name
Twitter
Name
次回の収益日
2025-03-12
Name
最新のSEC提出書
Name
ANIK's Discussions on Twitter

ANIK を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
ANIK
Anika Therapeutics Inc
11.39 157.76M 166.88M -74.18M 1.14M -5.07
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
152.63 68.05B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.77 46.58B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.745 43.71B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.50 18.40B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
305.38 13.23B 2.99B 1.21B 1.13B 25.06

Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-17 開始されました B. Riley Securities Buy
2024-11-01 繰り返されました Barrington Research Outperform
2023-08-14 アップグレード Barrington Research Mkt Perform → Outperform
2023-03-07 ダウングレード Barrington Research Outperform → Mkt Perform
2022-11-09 アップグレード Barrington Research Mkt Perform → Outperform
2022-10-14 再開されました Stephens Equal-Weight
2022-03-09 ダウングレード Barrington Research Outperform → Mkt Perform
2022-03-09 ダウングレード Stephens Overweight → Equal-Weight
2021-11-16 開始されました Stephens Overweight
2021-07-16 開始されました UBS Neutral
2020-12-16 アップグレード Barrington Research Mkt Perform → Outperform
2020-05-08 ダウングレード Barrington Research Outperform → Mkt Perform
2020-01-21 アップグレード Sidoti Neutral → Buy
2020-01-10 アップグレード First Analysis Sec Outperform → Strong Buy
2019-11-05 開始されました BWS Financial Sell
2019-09-24 繰り返されました Barrington Research Outperform
2019-09-23 ダウングレード First Analysis Sec Strong Buy → Outperform
2019-07-25 アップグレード First Analysis Sec Neutral → Strong Buy
2019-02-22 ダウングレード First Analysis Sec Outperform → Neutral
2019-02-22 ダウングレード Sidoti Buy → Neutral
2018-07-27 アップグレード Barrington Research Mkt Perform → Outperform
2018-06-20 ダウングレード Barrington Research Outperform → Mkt Perform
2018-06-20 ダウングレード First Analysis Sec Overweight → Equal-Weight
2018-05-04 アップグレード Barrington Research Mkt Perform → Outperform
2018-02-23 ダウングレード Barrington Research Outperform → Mkt Perform
2018-01-24 アップグレード First Analysis Sec Equal-Weight → Overweight
2017-10-27 繰り返されました Barrington Research Outperform
2016-05-09 アップグレード Singular Research BUY - Long-Term → Buy
2016-04-27 ダウングレード Northland Capital Outperform → Market Perform
2016-02-26 繰り返されました Barrington Research Outperform
すべてを表示

Anika Therapeutics Inc (ANIK) 最新ニュース

pulisher
07:48 AM

What drives Anika Therapeutics Inc. stock priceSkyrocketing returns - Autocar Professional

07:48 AM
pulisher
Jul 22, 2025

Is Anika Therapeutics Inc. a good long term investmentExponential return rates - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Anika Therapeutics Inc. stockRapid wealth multiplication - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Anika Therapeutics Inc. Stock Analysis and ForecastTriple returns potential - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why Anika Therapeutics Inc. stock attracts strong analyst attentionHigh Potential Stock Ideas - Newser

Jul 22, 2025
pulisher
Jul 18, 2025

Will Anika Therapeutics Inc. stock benefit from AI tech trendsROI Driven Alerts - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Why Anika Therapeutics Inc. stock is on top investor watchlistsLow Risk Profit Ideas - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Published on: 2025-07-17 22:25:16 - Newser

Jul 17, 2025
pulisher
Jul 17, 2025

how anika therapeutics inc. stock performs during market volatilityLow Risk Scalping Alerts - Newser

Jul 17, 2025
pulisher
Jul 16, 2025

Anika Therapeutics: Orthopedic Growth and Pipeline Progress Amid Headwinds - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025 - GlobeNewswire

Jul 16, 2025
pulisher
Jul 16, 2025

Orthopedics Leader Anika Announces Q2 2025 Earnings Call: Key Financial Results Coming July 30 - Stock Titan

Jul 16, 2025
pulisher
Jul 16, 2025

How Anika Therapeutics Inc. stock performs during market volatilityFree Stock Portfolio Optimization - Newser

Jul 16, 2025
pulisher
Jul 16, 2025

What makes Anika Therapeutics Inc. stock price move sharplyDaily Gain Forecast - Newser

Jul 16, 2025
pulisher
Jul 10, 2025

Anika Therapeutics Inc. (NASDAQ:ANIK) Shares Sold by Allspring Global Investments Holdings LLC - Defense World

Jul 10, 2025
pulisher
Jul 09, 2025

Breakthrough Growth Ahead: Adhesion Barrier Market Set to Surge - openPR.com

Jul 09, 2025
pulisher
Jul 04, 2025

Europe Viscosupplementation Market Growth in Future Scope - openPR.com

Jul 04, 2025
pulisher
Jul 03, 2025

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jul 03, 2025
pulisher
Jul 03, 2025

(ANIK) Technical Data - news.stocktradersdaily.com

Jul 03, 2025
pulisher
Jun 30, 2025

Anika Therapeutics, Inc.(NasdaqGS: ANIK) dropped from Russell Microcap Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

Anika Therapeutics, Inc.(NasdaqGS:ANIK) dropped from Russell 2000 Growth-Defensive Index - MarketScreener

Jun 30, 2025
pulisher
Jun 29, 2025

Anika Therapeutics, Inc.(NasdaqGS:ANIK) dropped from Russell Small Cap Comp Growth Index - MarketScreener

Jun 29, 2025
pulisher
Jun 28, 2025

ANIK SEC FilingsAnika Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 28, 2025
pulisher
Jun 24, 2025

Anika Therapeutics Approves Key Proposals at Annual Meeting - TipRanks

Jun 24, 2025
pulisher
Jun 24, 2025

Anika Therapeutics stockholders approve incentive plan amendment and elect directors - Investing.com

Jun 24, 2025
pulisher
Jun 15, 2025

Comparing Vivos (OTCMKTS:RDGL) & Anika Therapeutics (NASDAQ:ANIK) - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

Two Sigma Investments LP Cuts Stock Holdings in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

Jun 13, 2025
pulisher
Jun 10, 2025

Bank of America Corp DE Boosts Stake in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

Jun 10, 2025

Anika Therapeutics Inc (ANIK) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Anika Therapeutics Inc (ANIK) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Nunes Anne
SVP, Chief Operations Officer
Mar 17 '25
Option Exercise
0.00
3,637
0
21,722
Colleran David
EVP, General Counsel, Corp Sec
Mar 17 '25
Option Exercise
0.00
6,448
0
49,847
Blanchard Cheryl R
President, CEO, Director
Mar 17 '25
Option Exercise
0.00
25,132
0
209,472
Nunes Anne
SVP, Chief Operations Officer
Mar 11 '25
Option Exercise
0.00
2,561
0
18,837
Colleran David
EVP, General Counsel, Corp Sec
Mar 11 '25
Option Exercise
0.00
7,663
0
45,649
Blanchard Cheryl R
President, CEO, Director
Mar 11 '25
Option Exercise
0.00
30,060
0
197,015
Nunes Anne
SVP, Chief Operations Officer
Mar 10 '25
Option Exercise
0.00
3,296
0
17,235
Colleran David
EVP, General Counsel, Corp Sec
Mar 10 '25
Option Exercise
0.00
5,465
0
39,590
Blanchard Cheryl R
President, CEO, Director
Mar 10 '25
Option Exercise
0.00
20,002
0
172,826
Nunes Anne
SVP, Chief Operations Officer
Oct 01 '24
Option Exercise
0.00
2,491
0
14,211
$73.25
price up icon 1.18%
$15.01
price up icon 0.54%
$9.375
price up icon 1.46%
drug_manufacturers_specialty_generic RDY
$14.63
price up icon 1.56%
$133.34
price up icon 0.43%
$304.89
price up icon 2.39%
大文字化:     |  ボリューム (24 時間):